Drug Shortage Report for MYLAN-ZOPICLONE
Report ID | 2364 |
Drug Identification Number | 02238596 |
Brand name | MYLAN-ZOPICLONE |
Common or Proper name | Zopiclone |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ZOPICLONE |
Strength(s) | 7.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500BT, 100BT |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | Discontinued in ID 51665 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-03-22 | French | Compare |
v3 | 2017-03-22 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |